Evidence map›Paper›PMID 32945383›Full record

ArticleInternational journal of oncology2020

Resveratrol modulates the apoptosis and autophagic death of human lung adenocarcinoma A549 cells via a p53‑dependent pathway: Integrated bioinformatics analysis and experimental validation.

Yameng Fan, Jiaqiao Li, Yuxuan Yang, Xiaodan Zhao, Yamei Liu, Yude Jiang, Long Zhou, Yang Feng, Yan Yu, Yilong Cheng

Open access · hybridAbstract readValidation Study
In one paragraph

Article in International journal of oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  14. Article
  15. Article
  16. Resveratrol enhances AFrontiers in endocrinology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yameng Fan *School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Jiaqiao Li *School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Yuxuan Yang *School of Basic Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Xiaodan ZhaoSchool of Basic Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Yamei LiuSchool of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Yude JiangSchool of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Long ZhouSchool of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Yang FengSchool of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Yan YuSchool of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Yilong ChengSchool of Science, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol (RSV) has been reported to exhibit cytotoxic activity in multiple types of malignant cells; however, the mechanisms underlying the antitumor effects of RSV in non‑small‑cell lung cancer (NSCLC) cells remain undetermined. Combining bioinformatics analysis with experimental validation, the present study aimed to examine the effects of RSV on the apoptosis and autophagy of A549 NSCLC cells, and to determine the potential underlying molecular mechanisms. Bioinformatics analysis was used to determine the differentially expressed genes (DEGs) and identify the enriched biological functions and pathways associated with these DEGs following RSV treatment. Cell viability was determined by MTT assay, and flow cytometry and TUNEL assay were used to evaluate cell apoptosis. Monodansylcadaverine staining combined with a transmission electron microscope were used to evaluate the extent of autophagy. The expression levels of apoptosis‑, autophagy‑, or pathway‑associated molecular markers were measured by reverse transcription‑quantitative PCR and/or western blot analysis. By bioinformatics analysis, a total of 1,031 DEGs were identified in the RSV‑treated A549 cells, which were enriched in apoptosis‑, or autophagy‑related biological functions and the p53 signaling pathway. In validation experiments, RSV significantly reduced cell viability and initiated apoptosis, with an increase in the number of apoptotic cells; it also upregulated cleaved caspase‑3 expression and Bax expression, and downregulated the Bcl‑2 expression levels. Additionally, there was an increase in the accumulation of green dot‑like structures, indicative of autophagic vesicles, observed under a fluorescence microscope, and an increase in the presence of autophagic vacuoles observed using a transmission electron microscope following RSV treatment. Furthermore, the expression levels of the autophagy‑related proteins, LC3‑II/LC3‑I and Beclin‑1, were increased and p62 expression was decreased. 3‑methyladenine (3‑MA), an inhibitor of autophagy, partially reversed the RSV‑induced cytotoxic effects, but did not significantly alter the number of apoptotic cells. RSV elevated the p53 levels and decreased the phosphorylated (p‑)Mdm2 and p‑Akt levels. Pifithrin‑α, an inhibitor of p53, partially reduced RSV‑induced apoptosis and autophagy. On the whole, the results of the present study demonstrated that RSV initiates the apoptosis and autophagic death of A549 cells via the activation of the p53 signaling pathway, further highlighting the potential of RSV for the treatment of NSCLC.

Indexed as

A549 CellsAdenocarcinoma of LungAntioxidantsApoptosisAutophagyComputational BiologyDatabases, GeneticHumansLung NeoplasmsResveratrolSignal TransductionTumor Suppressor Protein p53AntioxidantsResveratrolTP53 protein, humanTumor Suppressor Protein p53apoptosisautophagybioinformaticsNSCLCresveratrol

Identifiers

PMID32945383
PMCPMC7473753
OpenAlexW3047877426

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.